leisure time -WSS

leisure time

author：Wikipedia 2025-10-01 23:00:37 - browse：4748

illustration of a colorful DNA strand, partly broken into pieces. -- health coverage from STAT — Adobe

BALTIMORE — An ambitious effort to cure HIV with CRISPR genome editing fell short in an early clinical trial, investigators announced Friday morning.

In the study, run by Excision BioTherapeutics, researchers tried to use the gene editing tool to address a chief reason HIV has been so hard to cure. While antiviral drugs can clear patients of replicating virus, HIV is able to worm its way into a patients’ own DNA in certain cells. If the patient ever stops taking medicines, those cells start pumping out HIV particles and the infection roars back.

Researchers hoped they could send CRISPR to those cells and, by cutting the HIV DNA lurking there at two spots, slice out the virus. In the Phase 1 trial, investigators administered the treatment to five patients. They then took three of them off conventional antiviral treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Medical experts exlpore how to eliminate bias in clinical algorithms

WSS

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

Gene therapy for Afghan refugees’ infant will be fully covered

Thousands protest in Iraq for a second day over burning of Quran in Sweden

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Apple is now the first public company to be valued at $3 trillion

The strange history of BMI, the body mass index

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Tuskegee Airman Raymond Cassagnol dies at 102

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Medical experts exlpore how to eliminate bias in clinical algorithms

Alkermes shareholders re

Why do we get seasonal allergies?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

340B reform proposal comes out of Senate working group

hotspot

GOP inquiry over gain

Bernie brings in new pharma CEOs to talk drug prices

A protest over insulin prices is seen as a fight for life

Cano Health’s bankruptcy is a warning for Medicare Advantage

Adopting new red light myopia treatments may be short

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

hotspot

hotspot

hotspot

explore